A Multiplexed Fluorescent Calcium and NFAT Reporter Gene Assay to Identify GPCR Agonists.

Heeral Sheth, Colleen Gorey, Nicole Roush, Shelly Smallman, Elizabeth Collantes, Maxine Santoro, Barbara Olson, Laura Fitzgerald, Paul H Lee, Xiqiang John Shen
{"title":"A Multiplexed Fluorescent Calcium and NFAT Reporter Gene Assay to Identify GPCR Agonists.","authors":"Heeral Sheth,&nbsp;Colleen Gorey,&nbsp;Nicole Roush,&nbsp;Shelly Smallman,&nbsp;Elizabeth Collantes,&nbsp;Maxine Santoro,&nbsp;Barbara Olson,&nbsp;Laura Fitzgerald,&nbsp;Paul H Lee,&nbsp;Xiqiang John Shen","doi":"10.2174/2213988501307010001","DOIUrl":null,"url":null,"abstract":"<p><p>Intracellular calcium response and resulting calcium signaling to an agonist-GPCR interaction are important for the measurement of compound activity in the GPCR drug development. The increase in cytosol calcium concentration can be measured by the fluorescent calcium indicator dye such as Fluo-4 in a quick assay (in 3-5 minutes) using the fluorescence imaging plate reader. The calcium signaling through the transcription factors such as NFAT that induces gene expression can be measured by the reporter gene assay that links to the expression of reporter enzyme such as the beta-lactamase that requires 5-hour incubation. We have evaluated a multiplexed assay that sequentially measures the calcium response to a GPCR agonist in a rapid fluorescent calcium dye assay, followed by a NFAT beta-lactamase assay, and compared them in the single assay format. We found that the agonist activity determined in the multiplexed assay were comparable with these determined in the single assay format and the Z' factors were all >0.5. Five active compounds were identified that were active in both calcium dye assay and beta-lactamase assay. Therefore, our results demonstrated the utility of this multiplexed calcium assay for screening of GPCR compounds that can cross validate the primary hits and help to eliminate the false positive compounds. </p>","PeriodicalId":10755,"journal":{"name":"Current Chemical Genomics and Translational Medicine","volume":"7 ","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2013-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/ab/CCGTM-7-1.PMC3854663.pdf","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Chemical Genomics and Translational Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2213988501307010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Intracellular calcium response and resulting calcium signaling to an agonist-GPCR interaction are important for the measurement of compound activity in the GPCR drug development. The increase in cytosol calcium concentration can be measured by the fluorescent calcium indicator dye such as Fluo-4 in a quick assay (in 3-5 minutes) using the fluorescence imaging plate reader. The calcium signaling through the transcription factors such as NFAT that induces gene expression can be measured by the reporter gene assay that links to the expression of reporter enzyme such as the beta-lactamase that requires 5-hour incubation. We have evaluated a multiplexed assay that sequentially measures the calcium response to a GPCR agonist in a rapid fluorescent calcium dye assay, followed by a NFAT beta-lactamase assay, and compared them in the single assay format. We found that the agonist activity determined in the multiplexed assay were comparable with these determined in the single assay format and the Z' factors were all >0.5. Five active compounds were identified that were active in both calcium dye assay and beta-lactamase assay. Therefore, our results demonstrated the utility of this multiplexed calcium assay for screening of GPCR compounds that can cross validate the primary hits and help to eliminate the false positive compounds.

Abstract Image

Abstract Image

Abstract Image

多路荧光钙和NFAT报告基因试验鉴定GPCR激动剂。
细胞内钙反应和由此产生的钙信号传导到激动剂-GPCR相互作用中,对于GPCR药物开发中化合物活性的测量是重要的。细胞质溶胶钙浓度的增加可以通过荧光钙指示剂(如Fluo-4)在快速测定(3-5分钟)中使用荧光成像板读取器来测量。通过转录因子(如NFAT)诱导基因表达的钙信号可以通过与报告酶(如β -内酰胺酶)表达相关的报告基因试验来测量,该试验需要5小时的孵育。我们已经评估了一种多重检测方法,该方法在快速荧光钙染料检测中依次测量钙对GPCR激动剂的反应,然后是NFAT β -内酰胺酶检测,并以单一检测格式比较它们。我们发现,在多重实验中测定的激动剂活性与在单一实验格式中测定的激动剂活性相当,并且Z'因子均>0.5。5种活性化合物在钙染料试验和β -内酰胺酶试验中均有活性。因此,我们的研究结果证明了这种多重钙分析在筛选GPCR化合物方面的效用,可以交叉验证主要命中并有助于消除假阳性化合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信